Clinical outcome benefits of pretreatment with levosimendan

Br J Anaesth. 2009 Jun;102(6):883-4; author reply 884. doi: 10.1093/bja/aep115.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiotonic Agents / therapeutic use*
  • Coronary Artery Bypass
  • Humans
  • Hydrazones / therapeutic use*
  • Intraoperative Care / methods
  • Pyridazines / therapeutic use*
  • Simendan
  • Stroke Volume / drug effects

Substances

  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Simendan